ACUTAAS.NS Profit & Loss
Acutaas Chemicals Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:32
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹6.17 Bn | ₹7.17 Bn | ₹10.07 Bn | ₹13.39 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.04 Bn | ₹0.07 Bn | ₹0.17 Bn | ₹0.42 Bn | OtherIncome |
| Total Income | ₹6.21 Bn | ₹7.25 Bn | ₹10.24 Bn | ₹13.81 Bn | Income |
| Cost of Materials Consumed | ₹3.46 Bn | ₹4.40 Bn | ₹5.70 Bn | ₹5.95 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-0.15 Bn | ₹-0.28 Bn | ₹-0.18 Bn | ₹-0.29 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹0.49 Bn | ₹0.63 Bn | ₹0.84 Bn | ₹1.18 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.02 Bn | ₹0.06 Bn | ₹0.06 Bn | ₹0.03 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹0.12 Bn | ₹0.16 Bn | ₹0.27 Bn | ₹0.36 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹1.14 Bn | ₹1.14 Bn | ₹1.39 Bn | ₹1.75 Bn | OtherExpenses |
| Total Expenses | ₹5.09 Bn | ₹6.11 Bn | ₹8.08 Bn | ₹8.98 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹1.12 Bn | ₹1.14 Bn | ₹2.16 Bn | ₹4.83 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹-0.32 Bn | ₹0.00 Bn | ₹0.00 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹1.12 Bn | ₹0.82 Bn | ₹2.16 Bn | ₹4.83 Bn | ProfitBeforeTax |
| Tax Expense | ₹0.29 Bn | ₹0.33 Bn | ₹0.56 Bn | ₹1.26 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹0.83 Bn | ₹0.49 Bn | ₹1.60 Bn | ₹3.56 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹0.00 Bn | ₹0.43 Bn | ₹1.59 Bn | ₹3.56 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹22.86 | ₹11.67 | ₹19.81 | ₹43.51 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹22.86 | ₹11.66 | ₹19.81 | ₹43.37 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from ACUTAAS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).